Covetrus Inc
NASDAQ:CVET
Covetrus Inc
Cost of Revenue
Covetrus Inc
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Covetrus Inc
NASDAQ:CVET
|
Cost of Revenue
-$3.7B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
Cardinal Health Inc
NYSE:CAH
|
Cost of Revenue
-$213.2B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-9%
|
|
Henry Schein Inc
NASDAQ:HSIC
|
Cost of Revenue
-$8.5B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-2%
|
|
Patterson Companies Inc
NASDAQ:PDCO
|
Cost of Revenue
-$5.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-7%
|
|
Mckesson Corp
NYSE:MCK
|
Cost of Revenue
-$296.4B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-9%
|
|
Cencora Inc
NYSE:COR
|
Cost of Revenue
-$267.1B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-10%
|
See Also
What is Covetrus Inc's Cost of Revenue?
Cost of Revenue
-3.7B
USD
Based on the financial report for Dec 31, 2021, Covetrus Inc's Cost of Revenue amounts to -3.7B USD.
What is Covetrus Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-6%
Over the last year, the Cost of Revenue growth was -5%. The average annual Cost of Revenue growth rates for Covetrus Inc have been -6% over the past three years , -6% over the past five years .